Endocrine gland derived-VEGF is down-regulated in human pituitary adenoma

Anticancer Research

Volumn 30, Issue 10, 2010, Pages 3981-3986

  Raica, Marius ^a   Coculescu, Mihail ^b   Cimpean, Anca Maria ^a   Ribatti, Domenico ^c  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

Author keywords

EG VEGF; Hypophysis; Immunohistochemistry; Pituitary adenoma

Indexed keywords

CORTICOTROPIN; FOLLITROPIN; GROWTH HORMONE; LUTEINIZING HORMONE; PROLACTIN; THYROTROPIN; VASCULOTROPIN;

ADENOHYPOPHYSIS; ARTICLE; BLOOD SAMPLING; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; ENDOCRINE GLAND; FOLLITROPIN BLOOD LEVEL; GENE EXPRESSION; GROWTH HORMONE BLOOD LEVEL; HISTOPATHOLOGY; HORMONE RELEASE; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE BLOOD LEVEL; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN SECRETION; RECEPTOR DOWN REGULATION; THYROTROPIN BLOOD LEVEL; TUMOR CELL;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; DOWN-REGULATION; FOLLICLE STIMULATING HORMONE; HUMAN GROWTH HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; LUTEINIZING HORMONE; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; PROLACTIN; THYROTROPIN; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 78650244561     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ and Ferrara N: Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 412: 877-884, 2001.
2. Lin R, LeCouter J, Kowalski J and Ferrara N: Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 277: 8724-8729, 2002.
3. Zhang L, Yang N, Conejo-Garcia JR, Katsaros D, Mohamed-Hadley A, Fracchioli S, Schlienger K, Toli A, Levine B, Rubin SC and Coukos G: Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Clin Cancer Res 9: 264-272, 2003. (Pubitemid 36109743)
4. Goi T, Fujioka M, Satoh Y, Tabata S, Koneri K, Nagano H, Hirono Y, Katayama K, Hirose K and Yamaguchi A: Angiogenesis and tumor proliferation/metastasis in human colorectal cancer cell line SW620 transfected with endocrine gland-derived vascular endothelial growth factor, as a new angiogenic factor. Cancer Res 64: 1906-1910, 2004.
5. Vilchis MA, Chavez B, Chan C, Robles-Diaz G and Diaz-Sanchez V: Expression and localization of endocrine gland-derived endothelial growth factor (EG-VEGF) in human pancreas and pancreatic adenocarcinoma. J Steroid Biochem Mol Biol 107: 37-41, 2007.
6. Ngan ESW, Sit FYL, Lee KL, Miao X, Yuan Z, Wang W, Nicholls JM, Wong KKY, Garcia-Barcelo M, Lui VCH and Tam PKH: Implications of endocrine gland-derived vascular endothelial growth factor/prokineticin-1 signaling in human neuroblastoma progression. Clin Cancer Res 13: 868-875, 2007.
7. Samson M, Peale FV, Frantz G, Rioux-Leclercq N, Rajpert-De Meyts E and Ferrara N: Human endocrine gland-derived vascular endothelial growth factor: expression early in development and in Leydig cells tumors suggests roles in normal and pathological testis angiogenesis. J Clin Endocrinol Metab 89: 4078-4088, 2004.
8. Ferrara N, Frantz G, LeCouter J, Dillard-Telm L, Pham T, Draksharapu A, Giordano T and Peale F: Differential expression of the angiogenic factor genes vascular endothelial growth factor (VEGF) and endocrine gland-derived VEGF in normal and polycystic human ovaries. Am J Pathol 162: 1881-1893, 2003.
9. Onofri C, Theodoropoulou M, Losa M, Uhl E, Lange M, Arzt E, Stalla GK and Renner U: Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours. J Endocrinol 191: 249-261, 2006.
10. Cohen AB and Lessell S: Angiogenesis and pituitary tumors. Semin Ophtalmol 24: 185-189, 2009.
11. Saeger W: Expression of growth factors in normal and neoplastic pituitary tissues. Endocr Pathol 11: 295-300, 2000.
12. Lloyd RV, Scheithauer BW, Koroki T, Vidal S, Kovacs K and Stefaneanu L: Vascular endothelial growth factor (VEGF) expression in human pituitary adenomas and carcinomas. Endocr Pathol 10: 229-235, 1999.
13. Cristina C, Perez-Milan MI, Luque G, Dulce RA, Sevlever G, Berner SI and Becu-Villalobos D: VEGF and CD31 association in pituitary adenoma. Endocr Pathol 21: 154-160, 2010.
14. Kurosaki M, Saegert W, Abe T and Ladecke DK: Expression of vascular endothelial growth factor in growth hormone-secreting pituitary adenomas: special reference to octreotide treatment. Neurol Res 30: 518-522, 2008.
15. Hoffmann P, Saoudi Y, Benharouga M, Graham CH, Schaal J-P, Mazouni C, Feige J-J and Alfaidy N: Role of EG-VEGF in human placentation: physiological and pathological implications. J Cell Mol Med 13: 2224-2235, 2009.
16. Lee YL, Chan YL, Chow WN, Ng EH, Lee KF, Yeung WS and Ho PC: Endocrine gland-derived vascular endothelial growth factor stimulates proliferation and tube formation in human uterine microvascular endothelial cell through the mitogen-activated protein kinase but not through the Akt pathway. Fertil Steril 91: 2163-2172, 2009.
17. LeCouter J, Lin R, Frantz G, Zhang Z, Hillan K and Ferrara N: Mouse endocrine gland-derived endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. Endocrinol 144: 2606-2616, 2003.
18. Nagano H, Goi T, Koneri K, Hirono Y, Katayama K and Yamaguchi A: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) expression in colorectal cancer. J Surg Oncol 96: 605-610, 2007.
19. Pasquali D, Rossi V, Staibano S, De Rosa G, Chieffi P, Prezioso D, Mirone V, Mascolo M, Tramontano D, Bellastella A and Sinisi AA: The endocrine-gland-derived vascular endothelial growth factor (EG-VEGF)/ prokineticin 1 and 2 and receptor expression in human prostate: up-regulation of EG-VEGF/prokineticin 1 with malignancy. Endocrinol 147: 4245-4251, 2006.